Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer
Keywords: نئوپلاسم مثانه یا سرطان مثانه; Bladder neoplasms; Drug therapy; Treatment outcome; Clinical trial